Tim Wigal

7.6k total citations · 1 hit paper
50 papers, 3.7k citations indexed

About

Tim Wigal is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tim Wigal has authored 50 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Psychiatry and Mental health, 15 papers in Cognitive Neuroscience and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tim Wigal's work include Attention Deficit Hyperactivity Disorder (34 papers), Child and Adolescent Psychosocial and Emotional Development (12 papers) and Children's Physical and Motor Development (7 papers). Tim Wigal is often cited by papers focused on Attention Deficit Hyperactivity Disorder (34 papers), Child and Adolescent Psychosocial and Emotional Development (12 papers) and Children's Physical and Motor Development (7 papers). Tim Wigal collaborates with scholars based in United States, Canada and United Kingdom. Tim Wigal's co-authors include James M. Swanson, Scott H. Kollins, Sharon B. Wigal, Howard Abikoff, C.G. Glabe, James L. Kennedy, S.B. Wigal, Abram Amsel, Edmund Sonuga‐Barke and James J. McGough and has published in prestigious journals such as JAMA, Journal of Neuroscience and PEDIATRICS.

In The Last Decade

Tim Wigal

49 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.

1996 560 citations James M. Swanson, S.B. Wigal et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim Wigal United States	27	2.7k	1.6k	919	644	617	50	3.7k
Mary V. Solanto United States	30	3.6k 1.3×	2.3k 1.5×	1.1k 1.2×	849 1.3×	735 1.2×	58	4.4k
Eric Taylor United Kingdom	29	2.2k 0.8×	1.3k 0.8×	919 1.0×	486 0.8×	568 0.9×	62	3.3k
Gunther H. Moll Germany	33	1.7k 0.6×	1.9k 1.2×	685 0.7×	487 0.8×	285 0.5×	108	3.5k
Sharon B. Wigal United States	38	3.6k 1.3×	1.5k 0.9×	968 1.1×	489 0.8×	976 1.6×	108	4.1k
Floyd R. Sallee United States	35	1.7k 0.6×	1.1k 0.7×	1.8k 2.0×	678 1.1×	256 0.4×	110	4.2k
Paramala Santosh United Kingdom	32	2.6k 1.0×	1.8k 1.1×	1.0k 1.1×	173 0.3×	493 0.8×	109	3.9k
Timothy Wigal United States	33	5.1k 1.8×	2.4k 1.5×	2.7k 3.0×	398 0.6×	1.5k 2.4×	52	6.1k
Gail Tripp Japan	23	1.8k 0.7×	1.4k 0.9×	627 0.7×	397 0.6×	587 1.0×	65	2.5k
Linmarie Sikich United States	28	1.8k 0.7×	1.5k 0.9×	988 1.1×	248 0.4×	273 0.4×	67	3.4k
Maria Nobile Italy	28	917 0.3×	897 0.6×	676 0.7×	284 0.4×	413 0.7×	118	2.5k

Countries citing papers authored by Tim Wigal

Since Specialization

Citations

This map shows the geographic impact of Tim Wigal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Wigal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Wigal more than expected).

Fields of papers citing papers by Tim Wigal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Wigal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Wigal. The network helps show where Tim Wigal may publish in the future.

Co-authorship network of co-authors of Tim Wigal

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Wigal. A scholar is included among the top collaborators of Tim Wigal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Wigal. Tim Wigal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wigal, Sharon B., Tim Wigal, Mary Hobart, et al.. (2020). <p>Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies</p>. Neuropsychiatric Disease and Treatment. Volume 16. 1411–1426. 26 indexed citations

Wigal, Tim, et al.. (2018). A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS Drugs. 32(3). 289–301. 21 indexed citations

Rasmussen, Jerod M., B. J. Casey, Theo G.M. van Erp, et al.. (2015). ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging and Behavior. 10(3). 761–771. 36 indexed citations

Wigal, Sharon B., Tim Wigal, Sabrina Schuck, et al.. (2011). Academic, Behavioral, and Cognitive Effects of OROS ^® Methylphenidate on Older Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 21(2). 121–131. 50 indexed citations

Lerner, Marc & Tim Wigal. (2008). Long-term Safety of Stimulant Medications Used to Treat Children with ADHD. Psychiatric Annals. 38(1). 43–51. 2 indexed citations

Lerner, Marc & Tim Wigal. (2008). Long-Term Safety of Stimulant Medications Used to Treat Children with ADHD. Pediatric Annals. 37(1). 37–45. 17 indexed citations

Lerner, Marc & Tim Wigal. (2008). Long-Term Safety of Stimulant Medications Used to Treat Children with ADHD. Journal of Psychosocial Nursing and Mental Health Services. 46(8). 38–48. 14 indexed citations

Ghuman, Jaswinder K., Mark A. Riddle, Benedetto Vitiello, et al.. (2007). Comorbidity Moderates Response to Methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 563–579. 59 indexed citations

Abikoff, Howard, Benedetto Vitiello, Mark A. Riddle, et al.. (2007). Methylphenidate Effects on Functional Outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 581–592. 64 indexed citations

10.

Wigal, Sharon B., Suneel Gupta, Laurence L. Greenhill, et al.. (2007). Pharmacokinetics of Methylphenidate in Preschoolers with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 17(2). 153–164. 52 indexed citations

11.

Murray, Desiree W., Scott H. Kollins, Kristina K. Hardy, et al.. (2007). Parent versus Teacher Ratings of Attention-Deficit/Hyperactivity Disorder Symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 605–619. 88 indexed citations

12.

Hardy, Kristina K., Scott H. Kollins, Desiree W. Murray, et al.. (2007). Factor Structure of Parent- and Teacher-Rated Attention-Deficit/Hyperactivity Disorder Symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 621–633. 42 indexed citations

13.

Vitiello, Benedetto, Howard Abikoff, Shirley Z. Chuang, et al.. (2007). Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 593–603. 56 indexed citations

14.

Swanson, James M., Robert K. Moyzis, James J. McGough, et al.. (2007). Effects of Source of DNA on Genotyping Success Rates and Allele Percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 635–645. 10 indexed citations

15.

Gehricke, Jean‐G., et al.. (2006). The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination. Nicotine & Tobacco Research. 8(1). 37–47. 64 indexed citations

16.

LaHoste, Gerald J., Tim Wigal, Bryan H. King, et al.. (2000). Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: Implications for treatment of tardive dyskinesia and hyperdopaminergic states.. Experimental and Clinical Psychopharmacology. 8(1). 125–132. 6 indexed citations

17.

Swanson, James M., et al.. (1996). Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.. PubMed. 1(2). 121–4. 560 indexed citations breakdown →

18.

Clevenger, Walter, et al.. (1994). Dental needs of persons with developmental disabilities in Orange County. Journal of Developmental and Physical Disabilities. 6(4). 299–309. 2 indexed citations

19.

Smith, Gregory J., James S. Miller, Tim Wigal, & Norman E. Spear. (1989). Facilitation of acquisition and retention in preweanling but not postweanling rats by the presence of familiar home-nest material. Behavioral and Neural Biology. 52(3). 370–385. 2 indexed citations

20.

Wigal, Tim, Paul L. Greene, & Abram Amsel. (1988). Effects on the partial reinforcement extinction effect and on physical and reflex development of short-term in utero exposure to ethanol at different periods of gestation.. Behavioral Neuroscience. 102(1). 51–53. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact